Kira Shteyman
Family · Woodland Hills, CANPI 1093917387
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 102 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 13.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $603 and has fallen 61.8% since, to $230 in 2025.
Across 102 payments — averaging $22.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$317
- Pfizer$258
- Novo Nordisk$202
- Bayer$194
- Johnson & Johnson$194
- Boehringer Ingelheim$192
- plus $927 from 18 others
What the payments were for
- Food & beverage$2,284100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 19 | $317 |
| Pfizer | 8 | $258 |
| Novo Nordisk | 9 | $202 |
| Bayer | 9 | $194 |
| Johnson & Johnson | 7 | $194 |
| Boehringer Ingelheim | 7 | $192 |
| GSK | 6 | $137 |
| Lilly USA, LLC | 4 | $92 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $88 |
| AstraZeneca | 4 | $87 |
| AbbVie | 4 | $86 |
| Dexcom, Inc. | 4 | $77 |
| Otsuka America Pharmaceutical, Inc. | 3 | $62 |
| Merck | 3 | $54 |
| Exact Sciences | 2 | $36 |
| Sanofi-aventis U.S. LLC | 1 | $32 |
| Hologic Sales And Service, LLC | 1 | $30 |
| Idorsia Pharmaceuticals US Inc | 1 | $24 |
| Nestle Healthcare Nutrition Inc. | 1 | $24 |
| Travere Therapeutics, Inc. | 1 | $23 |
| Calliditas Therapeutics US Inc. | 1 | $22 |
| Novartis | 1 | $21 |
| Lucid Diagnostics Inc. | 1 | $16 |
| Alnylam Pharmaceuticals Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PAXLOVID$124
How this compares
$2,284 in reported general payments places this provider in the 85th percentile of 10,634 family providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 41 | $416 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 16 | $346 |
| Nifedipine ErNifedipine | 22 | $343 |
| Levothyroxine Sodium | 54 | $318 |
| Zolpidem Tartrate | 47 | $229 |
| Alprazolam | 34 | $174 |
| Losartan Potassium | 37 | $150 |
| Vitamin D2Ergocalciferol (Vitamin D2) | 19 | $144 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 12 | $135 |
| Diazepam | 14 | $104 |
| Allopurinol | 18 | $104 |
| Rosuvastatin Calcium | 19 | $97 |
| Metformin Hcl | 18 | $71 |
| Lisinopril | 12 | $40 |
| Ibuprofen | 11 | $37 |
Paid to pharmacies, not to this prescriber.
Other family in Woodland Hills
- Lori RobertsonChino Hills$475K
- Annette ShonLos Angeles$406K
- Lisa HigginsHanford$311K
- Jennifer TougasBakersfield$302K
- Kim SchaferSacramento$288K
- Dawn MeyerSan Diego$270K
- Jennifer KangCerritos$255K
- Erin DwyerSan Diego$189K
- Phyllis CasonLos Angeles$187K
- Gabriel SchwartzSan Francisco$166K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.